1. Corporate Officers - D
2. Douglas Earl Martin

Insider Trading History of Douglas Earl Martin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Douglas Earl Martin since 2008. This trader's CIK number is 1362155. At the time of last reporting, Douglas Earl Martin was the SVP, General Counsel of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO). Also see all insider trading activities at Allogene Therapeutics, Inc..

Note that in the past Douglas Earl Martin also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Allogene Therapeutics, Inc. (ALLO) by Douglas Earl Martin

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	ALLO	0	$0	6,404	$10,950	0	$0

Yearly summary of insider trading at Biomimetic Therapeutics, Inc. (BMTI) by Douglas Earl Martin

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2012	BMTI	0	$0	53,561	$125,818	0	$0
2011	BMTI	0	$0	30,000	$89,283	0	$0
2010	BMTI	0	$0	17,799	$221,623	96,500	$350,295
2009	BMTI	0	$0	1,200	$10,140	0	$0
2008	BMTI	4,500	$62,379	0	$0	8,500	$30,855

Insider trading activities at 2 companies by Douglas Earl Martin:

1. Allogene Therapeutics, Inc. (ALLO)

2. Biomimetic Therapeutics, Inc. (BMTI)

Table 1. Insider trading of Allogene Therapeutics, Inc. (ALLO) by Douglas Earl Martin

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-02-03	ALLO	Sale	6,404	1.71	10,950

Table 2. Insider trading of Biomimetic Therapeutics, Inc. (BMTI) by Douglas Earl Martin

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2012-03-26	BMTI	Sale	1,100	2.35	2,585
2012-03-27	BMTI	Sale	5,000	2.34	11,700
2012-03-28	BMTI	Sale	47,461	2.35	111,533
2011-10-14	BMTI	Sale	3,000	3.06	9,165
2011-10-13	BMTI	Sale	3,000	2.98	8,943
2011-10-12	BMTI	Sale	3,000	2.99	8,970
2011-10-06	BMTI	Sale	3,000	2.99	8,964
2011-10-07	BMTI	Sale	3,000	3.02	9,045
2011-10-10	BMTI	Sale	3,000	2.97	8,910
2011-10-11	BMTI	Sale	3,000	3.00	9,015
2011-10-04	BMTI	Sale	3,000	2.89	8,679
2011-10-05	BMTI	Sale	3,000	2.94	8,835
2011-10-03	BMTI	Sale	3,000	2.92	8,757
2010-03-17	BMTI	Option Ex	25,500	3.63	92,565
2010-03-17	BMTI	Sale	5,000	13.30	66,500
2010-01-13	BMTI	Sale	12,799	12.12	155,123
2010-01-02	BMTI	Option Ex	34,000	3.63	123,420
2010-01-13	BMTI	Option Ex	37,000	3.63	134,310
2009-03-17	BMTI	Sale	1,200	8.45	10,140
2008-04-14	BMTI	Option Ex	8,500	3.63	30,855
2008-03-28	BMTI	Buy	1,000	9.05	9,050
2008-01-23	BMTI	Buy	3,500	15.24	53,329

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Douglas Earl Martin (SVP, General Counsel of Allogene Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month